A Comprehensive Drift-Adaptive Framework for Sustaining Model Performance in COVID-19 Detection From Dynamic Cough Audio Data: Model Development and Validation.

Publication date: Jun 03, 2025

The COVID-19 pandemic has highlighted the need for robust and adaptable diagnostic tools capable of detecting the disease from diverse and continuously evolving data sources. Machine learning models, particularly convolutional neural networks, are promising in this regard. However, the dynamic nature of real-world data can lead to model drift, where the model’s performance degrades over time, as the underlying data distribution changes due to evolving disease characteristics, demographic shifts, and variations in recording conditions. Addressing this challenge is crucial to maintaining the accuracy and reliability of these models in ongoing diagnostic applications. This study aims to develop a comprehensive framework that not only monitors model drift over time but also uses adaptation mechanisms to mitigate performance fluctuations in COVID-19 detection models trained on dynamic cough audio data. Two crowdsourced COVID-19 audio datasets, namely COVID-19 Sounds and Coswara, were used for development and evaluation purposes. Each dataset was divided into 2 distinct periods, namely the development period and postdevelopment period. A baseline convolutional neural network model was initially trained and evaluated using data (ie, coughs from COVID-19 Sounds and shallow coughs from Coswara dataset) from the development period. To detect changes in data distributions and the model’s performance between these periods, the maximum mean discrepancy distance was used. Upon detecting significant drift, a retraining procedure was triggered to update the baseline model. The study explored 2 model adaptation approaches, unsupervised domain adaptation and active learning, both of which were comparatively assessed. The baseline model achieved an area under the receiver operating characteristic curve of 69. 13% and a balanced accuracy of 63. 38% on the development test set of the COVID-19 Sounds dataset, while for the Coswara dataset, the corresponding values were 66. 8% and 61. 64%. A decline in performance was observed when the model was evaluated on data from the postdevelopment period, indicating the presence of model drift. The application of the unsupervised domain adaptation approach led to performance improvement in terms of balanced accuracy by up to 22% and 24% for the COVID-19 Sounds and Coswara datasets, respectively. The active learning approach yielded even greater improvement, corresponding to a balanced accuracy increase of up to 30% and 60% for the 2 datasets, respectively. The proposed framework successfully addresses the challenge of model drift in COVID-19 detection by enabling continuous adaptation to evolving data distributions. This approach ensures sustained model performance over time, contributing to the development of robust and adaptable diagnostic tools for COVID-19 and potentially other infectious diseases.

Open Access PDF

Concepts Keywords
Adaptable active learning
Covid Cough
Pandemic COVID-19
Postdevelopment COVID-19 detection
data distribution shift
Humans
Machine Learning
machine learning
maximum mean discrepancy
model degradation
Neural Networks, Computer
Reproducibility of Results
SARS-CoV-2
unsupervised domain adaptation

Semantics

Type Source Name
disease MESH COVID-19
disease MESH data sources
disease MESH infectious diseases
disease MESH Long Covid
disease MESH respiratory diseases
disease MESH uncertainty
disease IDO symptom
disease IDO process
disease MESH infections
disease IDO history
disease IDO infection
drug DRUGBANK Honey
drug DRUGBANK Aspartame
disease IDO algorithm
drug DRUGBANK Saquinavir
disease MESH aids
disease MESH COPD
disease IDO assay
disease MESH obstructive sleep apnea
disease MESH diabetes mellitus
drug DRUGBANK Dextrose unspecified form
disease MESH influenza
disease MESH critically ill
drug DRUGBANK Guanosine
disease MESH tumor
disease IDO cell
drug DRUGBANK (S)-Des-Me-Ampa
disease IDO production
drug DRUGBANK Sulpiride
disease MESH emergency
disease MESH cardiac arrest
disease IDO object
disease MESH neural tube defects
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)